E ngineered variants of fluorescent proteins (FPs), originally cloned from marine organisms of the phylum Cnidaria, have provided researchers with a valuable set of tools for the minimally invasive imaging of the spatiotemporal dynamics of biomolecules in live cells and tissues.
ngineered variants of fluorescent proteins (FPs), originally cloned from marine organisms of the phylum Cnidaria, have provided researchers with a valuable set of tools for the minimally invasive imaging of the spatiotemporal dynamics of biomolecules in live cells and tissues. 1, 2 To use a FP to image the dynamics of a protein, a researcher first creates a genetic fusion of the FP gene and the gene encoding the protein of interest. The fusion gene is then introduced into cells and, using the endogenous transcriptional and translational machinery, the cells produce fluorescently labeled proteins in situ. In such applications the FP can be considered a passive participant that provides a steadfast fluorescence signal that is proportional to concentration but insensitive to other parameters.
Engineering of FP variants that are active reporters of cellular biochemistry (i.e., intracellular biosensors) has required the development of strategies that enable the fluorescence intensity or color of a FP-containing construct to be modulated in response to a change in its environment. 3, 4 One strategy that has proven particularly useful is the use of F€ orster resonance energy transfer (FRET) 5 from a more blue-shifted donor FP to a more redshifted acceptor FP. A change in FRET efficiency, due to a change in distance or relative orientation between the two FPs, 6 causes a ratiometric change in emission that is imaged in a typical FP FRET experiment. The prototypical FRET-based calcium ion (Ca 2+ ) biosensors are collectively known as cameleons and are created by genetically fusing the Ca 2+ -binding protein calmodulin (CaM) and the CaM-binding region of chicken myosin light chain kinase (M13) (i.e., the sensing domain) between the two FPs of a FRET pair. 7 Binding of Ca 2+ to CaM leads to the intramolecular binding of CaM and M13 and a change in the orientation and/or distance between the FPs. Although there is a growing demand for FP-based methods for monitoring multiple biological parameters in a single cell, 8 the broad spectral profiles of FP FRET pairs have, in most cases, meant that only a single biosensor could be ratiometrically imaged in one experiment. To achieve multiparameter imaging, researchers have tended to take hybrid approaches such as the use of cyan FP (CFP)-yellow FP (YFP) FRET-based biosensors with spectrally distinct hues of synthetic dye probes. 8 Yet other solutions use multiple intensiometric probes 9 or spectral unmixing of the emission from multiple ratiometric probes. 10 Arguably, these alternative methods sacrifice some of the key advantages of ratiometric imaging. Specifically, it is inherently quantitative, it is technically simple, it is inexpensive and uses common equipment, and it can be applied to a multitude of biological questions.
As part of our ongoing efforts to reconcile multiparameter imaging with FP-based imaging, we previously developed a pair of spectrally distinct FP FRET pairs, mAmetrine-tdTomato ( Figure 1A ) and mTFP1-mCitrine ( Figure 1B) , that both provide strong sensitized emission and, with appropriate filter choice, can be uniquely excited in each other's presence. 11 For the sake of brevity, we refer to the mAmetrine-tdTomato pair as "Yin" and the mTFP1-mCitrine pair as "Yang". To explore the utility of these spectrally distinct FRET pairs, we constructed ABSTRACT: As one of the principal cytoplasmic second messengers, the calcium ion (Ca 2+ ) is central to a variety of intracellular signal transduction pathways. Accordingly, there is a sustained interest in methods for spatially-and temporally resolved imaging of the concentration of Ca 2+ in live cells using noninvasive methods such as genetically encoded biosensors based on F€ orster resonance energy transfer (FRET) between fluorescent proteins (FPs). In recent years, protein-engineering efforts have provided the research community with FRETbased Ca 2+ biosensors that are dramatically improved in terms of enhanced emission ratio change and optimized Ca 2+ affinity for various applications. We now report the development and systematic optimization of a pair of spectrally distinct FRET-based biosensors that enable the simultaneous imaging of Ca 2+ in two compartments of a single cell without substantial spectral crosstalk between emission channels. Furthermore, we demonstrate that these new biosensors can be used in conjunction with previously reported caspase-3 substrates based on the same set of FRET pairs.
biosensors of caspase-3 proteolytic activity (DEVDYin and DEVDYang) and used them to determine the delay between the onset of caspase-3 activity in the cytoplasm and the nucleus during apoptosis. 11 Other workers have explored the combination of CFP-YFP and a second pair based on an orange FP (OFP) and a red FP (RFP), as spectrally distinct FRET pairs.
12À14 Such pairs have enabled multiparameter imaging, though their utility tends to be limited by the relatively poor sensitized emission of the RFP acceptors.
We now report the construction, optimization, and application of cameleon-type Ca 2+ biosensors based on an improved version of the Yin FRET pair combined with the original Yang FRET pair. Using these optimized biosensors, we have demonstrated that it is feasible to image Ca 2+ dynamics in two subcellular compartments or Ca 2+ and caspase-3 activity in the same subcellular compartment.
' EXPERIMENTAL METHODS General Methods. Synthetic DNA oligonucleotides were purchased from Integrated DNA Technologies (Coralville, IA). PCR products and products of restriction digestion were purified by gel electrophoresis and extracted using either the GeneJET gel extraction kit (Fermentas, ON) or the QIAquick gel extraction kit (QIAGEN, Valencia, CA). Plasmid DNA was purified using either the GeneJET Plasmid Miniprep Kit (Fermentas, ON) or the QIAprep Spin Miniprep kit (QIAGEN, Valencia, CA). Restriction endonucleases were purchased from either Invitrogen or New England Biolabs. Dye terminator cycle sequencing using the BigDye (Applied Biosystems) was used to confirm the complete cDNA sequences for all fusion constructs. Sequencing reactions were analyzed at the University of Alberta Molecular Biology Service Unit (MBSU). All filters for fluorescence screening and imaging were purchased from Chroma Technology (Rockingham, VT), Omega Filters (Brattleboro, VT), or Semrock (Rochester, NY).
Engineering and Directed Evolution of mAmetrine. Overlap-extension PCR was used to create the initial gene encoding cpmAmetrine-173 with a randomized residue (i.e., codon NNK, where N = A, G, C, T and K = G or T) at both termini. This initial library was screened as described below. In later rounds of directed evolution, error-prone PCR with Taq polymerase in the presence of MnCl 2 (200 μM) was used out to create libraries of mAmetrine with random mutations. 15 Purified PCR products were digested with Xho1 and EcoR1 and ligated into similarly digested pBAD/His B expression plasmid (Invitrogen). Electrocompetent Escherichia coli strain DH10B (Invitrogen) was transformed and plated on LB/agar plates supplemented with ampicillin (0.1 mg/mL) and L-arabinose (0.02%). Plates were incubated at 37°C for 14 h prior to screening.
To screen for bright cpmAmetrine-173 variants, colonies grown on a 10 cm Petri dish were illuminated with light from a 175 W xenon-arc lamp (Sutter) that had been passed through a bandpass filter wheel. Colony fluorescence was imaged with a Retiga 1300i 12-bit CCD camera (QImaging) equipped with a second filter wheel. For each dish, three images were acquired: excitation 375À415 nm, emission 440À480 nm; excitation 490À510 nm, emission 520À550 nm; and excitation 375À415 nm, emission 520À550 nm. Colonies with the highest ratio of fluorescence intensity in the latter image, relative to fluorescence intensity in the other two images, were picked.
To screen libraries of mAmetrine variants for improved photostability, an image (excitation 375À415 nm, emission 520À550 nm) of the plate was first acquired. The Petri dish was then placed in a custom-made photobleaching chamber and illuminated for 30 min by six 9 Â 11 arrays of 405 nm light emitting diodes (OptoDiode Corporation, Newbury Park, CA). The dish was then imaged again using the same filter set. Image Pro plus (Media Cybernetics, Bethesda, MD) was used for image processing, and a custom macro provided a list of the mean intensities for each colony in both images. Colonies with the highest intensity ratio of yellow fluorescence after photobleaching to yellow fluorescence before photobleaching were picked and used as templates for the following round of library creation.
Construction of CaYang and CaYin Variants. We previously reported a version of yellow cameleon 3.3 (YC3.3) 16 in which CFP has been replaced with mTFP1. 17 This mTFP1-YC3.3 (i.e., CaYang0.1) coding sequence is between the Xho1 (5 0 end) and EcoR1 (3 0 end) sites of pBAD/His B and contains a Sph1 site after mTFP1 (1À220; numbered as in ref 17 ) and a Sac1 before Citrine (a YFP). Routine plasmid digestion and ligation with appropriately digested PCR product was used to replace Citrine with mCitrine 18 or cpVenus-173. 19 Variants with the YC3.3 CaM/M13 portion replaced with the analogous portion from either YC4.3 or D1 were similarly constructed. 20 To generate CaYin0.1, a series of sequential digestions and ligations of the CaYang0.1 in pBAD/His B were performed. Specifically, mTFP1 was swapped with mAmetrine, 11 the YC3.3-derived CaM/M13 portion was swapped with the analogous portion of YC2.1, 7 and Citrine was swapped with tdTomato. 21 The domain organization of all CaYang and CaYin variants is provided in Figure 2 . All variants were expressed in E. coli and purified as described below. Table S-1 in the Supporting Information. Linkers were modified using a PCR procedure in which the cDNA encoding the D3 domain of CaYin0.9 was amplified with appropriately modified forward and reverse primers that contained a Sph1 site and a Sac1 site, respectively. PCR products were double digested and ligated (T4 ligase, Invitrogen) into a similarly digested pBAD/His B CaYin0.9 plasmid.
Protein Purification and Characterization. E. coli strain ElectroMAX DH10B (Invitrogen) was transformed by electroporation with a pBAD/His B containing the gene of interest. A single colony was used to inoculate a 4 mL culture that was grown overnight (37°C, 225 rpm) before being diluted into 0.5 L of LB medium supplemented with ampicillin. This culture was grown (37°C, 225 rpm) to an optical density of 0.6, induced with 0.02% L-arabinose, and cultured for 24 h at 28°C (FRET constructs) or 37°C (mAmetrine variants). Cells were harvested by centrifugation and lysed by cell disruptor (Constant Systems). All proteins were purified by Ni-NTA chromatography (Amersham) and then dialyzed into phosphate buffer saline (pH 7.4). FRET constructs were further purified by size exclusion column chromatography (Amersham Superdex 75 prep).
The alkaline-denaturation method was used to determine the extinction coefficients of mAmetrine variants. 22 The quantum yield of cpmAmetrine-173 and mAmetrine1.2 were determined using mAmetrine as a reference standard. Fluorescence and absorbance spectra were recorded on a QuantaMaster spectrofluorometer (Photon Technology International) and a DU-800 UVÀvisible spectrophotometer (Beckman), respectively.
The fluorescence response of Ca 2+ biosensors was determined by mixing the FRET construct (300 nM) with an equal volume of 500 mM CaCl 2 or 200 μM ethylene glycol-bis-(2-aminoethyl)-N,N,N 0 ,N 0 -tetraacetic acid (EGTA) in Tris-buffered saline (pH 7.4). To determine the K d for Ca 2+ , the fluorescence response of Ca 2+ biosensors was determined in buffers having free Ca 2+ ranging from 17 nM to 1 mM. Buffers were prepared by mixing of a 10 mM K 2 EGTA and a 10 mM CaEGTA solution containing 100 mM KCl and 30 mM MOPS buffer, pH 7.2 in deionized water. Buffers with free Ca 2+ above 100 μM were made by dilution of a 1 mM Ca 2+ buffer stock. Construction of Mammalian Expression Plasmids. A modified pcDNA3 (Invitrogen) plasmid, with a Xho1 site and an EcoR1 site in the same reading frame as the equivalent sites of the pBAD/His B plasmid, was used for mammalian cell expression. The mAmetrine, mAmetrine1.2, CaYin1, and CaYang1 constructs in pBAD/His B were treated with Xho1 and EcoR1 and ligated with similarly treated pcDNA3. For targeting to the nucleus, three copies of the nuclear localization sequence (NLS) DPKKKRKV were fused to the C-terminus. For targeting to the cytoplasm, a nuclear export sequence (NES) LALKLAGL-DIGS was fused to the C-terminus.
General Methods for Live Cell Imaging. All DNA for mammalian cell transfection was purified by the Plasmid Midiprep kit (Qiagen). Human cervical cancer cells (HeLa) were cultured in Dulbecco's modified Eagle medium (DMEM) (Invitrogen) supplemented with 10% fetal bovine serum (FBS) (Sigma) at 37°C. Cells in 35 mm imaging dishes were incubated with 1 mL of DMEM (FBS free) for 30 min and then transfected with 1 μg of plasmid DNA that had been mixed with 2 μL of Turbofect Protein Transfection Reagent (Fermentas) in 0.1 mL of DMEM (FBS free). The culture media was changed back to DMEM with 10% FBS after 2.5 h incubation at 37°C. Imaging was conducted 24À36 h post-transfection with cells at room temperature in HEPES (25 mM) buffered Hanks' Balanced Salt Solution (HHBSS) containing no phenol red or Ca 2+ . Imaging was carried on an inverted Nikon Eclipse Ti microscope equipped with a 150 W Lumen 200 metal halide lamp (Prior Scientific) with a 25% neutral density filter, a 40Â objective (NA = 0.95, air), and a 16-bit 512SC QuantEM CCD (Photometrics). Images were acquired every 5À10 s with exposure times of 100À300 ms. The NIS-Elements AR 3.0 software package (Nikon) was used for computer control and image analysis. Filters are provided in Table S-2 in the Supporting Information.
Photobleaching. A field of view containing 5À15 HeLa cells (previously transfected with NLS-tagged mAmetrine or mAmetrine1.2) was located on a cover slide using minimal excitation light intensity. These cells were then illuminated using the maximum intensity of the light source, with images acquired every 5 s for the first 1 min, every 20 s for another 2 min, and every 40 s until the cells had bleached to less than the half of the initial intensity. Nuclei with approximately equal sizes and initial intensities were used for data analysis.
Ca
2+ Imaging and Induction of Apoptosis. HeLa cells were treated as described above and then imaged for 2 min prior to addition of histamine (30 μM), an agonist that triggers oscillations of intracellular Ca 2+ concentration. The cells were then imaged for 15À20 min before the buffer was exchanged twice with HHBSS and finally replaced with HHBSS containing 5 mM Ca 2+ and 5 μM ionomycin (a Ca 2+ ionophore). The cell were Analytical Chemistry ARTICLE imaged 15 min before the buffer was once again exchanged and replaced with HHBSS containing 10 mM EGTA and 5 μM ionomycin. Imaging was then continued for another 15 min. To induce apoptosis, the nonspecific kinase inhibitor staurosporine was added into culture medium to the final concentration of 2 μM between 24 to 48 h post-transfection. Cells were maintained in HHBSS and subjected to imaging with 1 min interval for 4À6 h.
' RESULTS AND DISCUSSION Optimization of CaYang. We have designated our previously reported Ca 2+ biosensor, originally constructed by replacing the CFP portion of YC3.3 with mTFP1, 17 as CaYang0.1. The 35% ratio change exhibited by CaYang0.1 is diminished relative to YC3.3. 16, 17 In an effort to improve the performance of the CaYang0.1 construct, we replaced the YC3.3 sensing domain (containing CaM E104Q) with the analogous domain of YC4.3 (containing CaM E31Q) 7 to produce CaYang0.2 or with D1 (engineered to have 4 charge-reversed salt-bridges) to produce CaYang0.3 (Figure 2) . 20 The CaYang0.3 variant showed an improved dynamic range of 57% (Table S-3 in the Supporting Information). In an attempt to further improve the FRET response, the acceptor, a YFP known as Citrine, 16 was replaced with a circularly permuted YFP known as cp173Venus. 19 The rationale for this replacement is that it was expected to alter the donorÀacceptor dipoleÀdipole orientation and, accordingly, the FRET efficiency. Fortunately, this modification did result in a improvement in ratio change (Table S-3 in the Supporting Information and Figure 3A) , and so the resulting construct was designated CaYang1. In vitro characterization of CaYang1 revealed that the biosensor had a biphasic response to Ca 2+ ( Figure 3D ), similar to that reported for the parent D1 cameleon based on CFP and YFP. 20 Fitting the data to a two-site binding model gave K d values of 1.04 ( 0.03 and 66.8 ( 4.6 μM.
Engineering mAmetrine for Improved Performance in CaYin. As a first step toward the eventual goal of developing an optimized CaYin construct, we first attempted to enhance the relatively poor photostability 11 of mAmetrine through directed evolution.
Libraries of mAmetrine variants were created by either genetically randomizing a specific amino acid residue to all 20 possible amino acids or by random mutation of the whole gene. These libraries were then screened in a colony format using a three-step protocol in which the colonies were imaged, then bleached, and then imaged again. Colonies with the highest ratio of intensity after bleaching relative to before bleaching were picked for further characterization. An attempt to improve the photostability of mAmetrine by introducing the V224R mutation, which was previously reported to provide a 40-fold photostability enhancement in a blue FP, 23 led to a nonfluorescent variant. Randomization of position V224, either alone or in combination with randomization of the adjacent Q69 and A72 positions, provided no variants with improved photostability. We therefore turned to library creation by random mutagenesis of the mAmetrine gene. Following successive rounds of generating and screening random libraries, we eventually identified mAmetrine1.2. The spectral profile ( Figure 4A ) and properties (Table 1 ) of mAmetrine1.2 are very similar to mAmetrine, with the primary differences being a decreased fluorescence pK a for mAmetrine1.2 (5.8 vs 6.0; Figure 4B ) and a 3.3-fold increase in photobleaching halftime ( Figure 4C ). Interestingly all nine mutations (K26R, T43I, K52E, S99F, V147A, E172K, D190G, S192P, and N212Y) that differentiate mAmetrine1.2 from mAmetrine have side chains directed toward the outside of the β-barrel and six of these are located in loop regions between β-strands ( Figure 4D) . The mechanism by which these mutations confer improved photostability is currently unclear.
It is well established that swapping a FP in a FRET pair with a circularly permuted version of the same FP can provide substantial improvements in the dynamic range of a FRET-based biosensor.
19,24 Indeed, we used such a modification to improve CaYang as described above. As part of our effort to improve the CaYin biosensor, we set out to create a circularly permuted analogue of mAmetrine with new termini at position 173 (cpmAmetrine-173) and a five-residue peptide linker (GGSGG) connecting the original termini. As the new termini of would be located at the opposite end of the β-barrel from the original N-and C-termini, cpmAmetrine-173 would provide a distinct dipoleÀdipole orientation in the context of the FRET pair.
As our initially constructed version of cpmAmetrine-173 suffered from poor folding efficiency and low brightness, we employed directed evolution to improve its properties. To create an initial library of variants, a randomized residue was appended to each of the new termini to produce 400 (i.e., 20 2 ) possible protein variants. Following library screening in E. coli colonies, DNA sequencing of the brightest variant revealed that it had a lysine at the N-terminus and a proline at the C-terminus. However, this variant only retained about 10% of the brightness of mAmetrine when expressed in E. coli grown overnight at 37°C. To further improve the fluorescent brightness, we performed five sequential rounds of library creation by errorprone PCR and screening. The brightest variant from the fifth round was designated as cpmAmetrine-173. Characterization of purified cpmAmetrine-173 revealed that the intrinsic brightness (i.e., the product of quantum yield and extinction coefficient) is essentially identical to that of mAmetrine (Table 1) , though E. coli colonies expressing the protein are only about 80% as bright as colonies expressing mAmetrine. This discrepancy may reflect a reduced efficiency of protein folding, since the intrinsic brightness is measured using only properly folded and soluble protein. In addition to being circularly permuted and having an Analytical Chemistry ARTICLE appended 5 0 lysine and 3 0 proline, cpmAmetrine-173 has seven mutations (E32G, I123V, K131R, E142G, N144S, A181V, and Q204R) relative to mAmetrine ( Figure 4E ).
Optimization of CaYin by Domain Rearrangements. To construct a Ca 2+ -specific biosensor that would be spectrally distinct from CaYang, we constructed cameleon type constructs using the Yin FRET pair. As with the CaYang biosensor, we initially attempted a variety of domain combinations, with particular emphasis placed on exploring different arrangements of tdTomato, the binding domain of D3, 24 and the various versions of mAmetrine we now had in hand (Figure 2) . The D3 binding domain has been reported to have a K d that is well matched to the detection of Ca 2+ in the cytoplasm and has the added advantage of being engineered to not bind to endogenous CaM. 24, 25 Of the 10 variations tested, the construct with the largest ratio change (70%; Table S-3 in the Supporting Information) was CaYin0.9, a biosensor composed of tdTomato followed by the D3 Ca 2+ binding motif and mAmetrine1.2.
Optimization of CaYin by Linker Length Modification. Although we had tested 10 distinct domain alterations in an effort to optimize the Ca 2+ -dependent ratio change of CaYin, we remained unsatisfied with the 70% ratio change of our best variant, CaYin0.9 (Table S-3 in the Supporting Information and Figure 3B ). In an effort to further improve the ratio change, we turned to linker adjustment as an alternative method to optimize biosensor performance. 6 Accordingly, we individually constructed, purified, and tested 17 additional variants of CaYin0.9 in which the linker between tdTomato and CaM and the linker between M13 and mAmetrine1.2 was varied in length (Table S-1 and Figure S-1 in the Supporting Information). As previously reported for an analogous optimization effort, 26 there was no clear trend in the observed responses to Ca 2+ as a function of linker length. Indeed, adjustments as small as changing the length of the tdTomato to CaM linker from two to four residues, at a fixed M13 to mAmetrine1.2 linker of two residues, inverted the direction of the ratio change. We also explored the effect of truncating up to five residues from the N-terminus of CaM and up to six residues from the C-terminus of M13. The variant with the largest ratio change (105%; Figure 3C ) had two residues deleted from the N-terminus of CaM and six residues deleted from the C-terminus of M13. Further in vitro characterization of this variant, designated as CaYin1, revealed a K d for Ca 2+ of 0.87 ( 0.07 μM ( Figure 3E ).
Multiparameter Imaging with Ca
2+ and Caspase Biosensors. To test the utility of CaYin1 and CaYang1 for multiparameter imaging, we coexpressed both biosensors in HeLa cells and performed ratiometric fluorescence imaging with appropriate filter combinations (Table S-2 in the Supporting Information and Figure 5AÀD ). Similarly to our previously reported imaging experiments with DEVDYin and DEVDYang, 11 CaYin1 was targeted to the cytoplasm using a nuclear-exclusion sequence (NES) and CaYang1 was targeted to the nucleus using a nuclear localization sequence (NLS). Upon stimulation of Ca 2+ release imaging experiments. To assess whether biosensors based on the Yin and Yang FRET pairs could be used in the same cellular compartment, we coexpressed both DEVDYin and CaYang1 in HeLa cells and performed ratiometric imaging as with the CaYin1 and CaYang1 combination ( Figure 5EÀH ). This experiment directly assessed the spectral orthogonality of the two sensors, since Ca 2+ spikes following histamine treatment were expected to be visualized as increases in the Yang emission ratio but not in the Yin emission ratio. Likewise, the loss of FRET following cleavage of DEVDYin by caspase-3 was expected to be visualized as a decrease in the Yin emission ratio but not in the Yang emission ratio. Satisfyingly, we observed that Ca 2+ -dependent ratio changes in the Yang emission ratio resulted in no concomitant change in the Yin emission ratio ( Figure 5F ), and the dramatic decrease in the Yin emission ratio that followed caspase-3 dependent cleavage resulted in no substantial change in the Yang emission ratio ( Figure 5E ). Correcting the emission intensities for inter-FRET pair spectral crosstalk 11 produced time course traces that were qualitatively similar to the uncorrected traces (Table S- 
' CONCLUSIONS
We have described the development and optimization of a pair of FP-based Ca 2+ biosensors that are spectrally distinct and can be imaged in the same cell. We have also demonstrated that one of these Ca 2+ biosensors, paired with one of the previously reported caspase-3 biosensors based on the same FRET pairs, enables ratiometric imaging of both Ca 2+ and caspase-3 activity in the cytoplasm of a single cell. With the recent development of the intensiometric red-fluorescent FP-based Ca 2+ indicator R-GECO1, 9 analogous multiparameter imaging could now be accomplished with the combined use of R-GECO1 and a CFP-YFP FRET-based Ca 2+ indicator 25 or caspase-3 indicator. 27 Relative to this alternative approach, the use of the Yin and Yang FRET pairs provides two advantages. The first advantage is that both biosensors can be imaged ratiometrically, thus providing greater ease of quantitation. The second advantage is that, in principle, any pair of biosensors from the vast number of existing CFP-YFP FRET-based biosensors could be converted to the Yin and Yang FRET pairs. In contrast, there are very few examples of intensiometric biosensors that could be converted to an R-GECO1-like design, severely limiting the versatility of such an approach. As highlighted by the present work, the primary disadvantage of the Yin and Yang FRET pairs (or any other novel FRET pair) is the substantial challenge associated with converting an optimized CFP-YFP FRET based biosensor to an alternate FRET pair. As others have shown, the FRET response of a particular biosensor is critically dependent on the physical properties of the FPs.
28 Accordingly, switching to a different FRET pair, particularly one in which the FPs are derived from different species, may require the onerous task of biosensor optimization to be repeated. In the case of Yin and Yang, the necessary reoptimization effort is doubled. For these reasons, we suggest that the development and optimization of an effective OFP-RFP FRET pair is an important future direction, as it could be used in conjunction with previously optimized CFP-YFP biosensors. 
